ÂÜÀòÂÒÂ×

Chong-Hui Gu, currently working at Foghorn Therapeutics as the Head of CMC and QA, has an extensive background in the pharmaceutical industry. Prior to joining Foghorn Therapeutics, Chong-Hui held roles at Agios Pharmaceuticals as the Head of CMC and DHODH program leader, and at Vertex Pharmaceuticals as a Research Fellow. Chong-Hui also gained experience at Bristol-Myers Squibb as a Senior Research Investigator. Chong-Hui's educational background includes attending the University of Minnesota from 1996 to 2001.